Published in J Am Soc Nephrol on August 01, 2002
Association of race and age with survival among patients undergoing dialysis. JAMA (2011) 5.82
Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med (2009) 3.69
Empirical efficiency maximization: improved locally efficient covariate adjustment in randomized experiments and survival analysis. Int J Biostat (2008) 2.06
Kidney transplant access in the Southeast: view from the bottom. Am J Transplant (2014) 1.71
Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian Organ Replacement Registry 2001-2004. Clin J Am Soc Nephrol (2008) 1.61
Higher serum creatinine concentrations in black patients with chronic kidney disease: beyond nutritional status and body composition. Clin J Am Soc Nephrol (2008) 1.57
Race and mortality after acute renal failure. J Am Soc Nephrol (2007) 1.35
Extended instrumental variables estimation for overall effects. Int J Biostat (2008) 1.09
Racial and gender differences in arteriovenous fistula use among incident hemodialysis patients. Am J Nephrol (2010) 1.04
Use and safety of heparin-free maintenance hemodialysis in the USA. Nephrol Dial Transplant (2013) 0.94
Racial disparities in kidney disease outcomes. Semin Nephrol (2013) 0.93
Is there "cherry picking" in the ESRD Program? Perceptions from a Dialysis Provider Survey. Clin J Am Soc Nephrol (2009) 0.93
Synthetic vascular hemodialysis access versus native arteriovenous fistula: a cost-utility analysis. Ann Surg (2012) 0.88
Meeting KDOQI guideline goals at hemodialysis initiation and survival during the first year. Clin J Am Soc Nephrol (2010) 0.88
The Survival Benefit of "Fistula First, Catheter Last" in Hemodialysis Is Primarily Due to Patient Factors. J Am Soc Nephrol (2016) 0.86
Sociodemographic and geographic predictors of quality of care in United States patients with end-stage renal disease due to lupus nephritis. Arthritis Rheumatol (2015) 0.83
Duration of temporary catheter use for hemodialysis: an observational, prospective evaluation of renal units in Brazil. BMC Nephrol (2011) 0.81
Nutritional and inflammatory axis of racial survival disparities. Semin Dial (2012) 0.80
Racial and Ethnic Disparities in Survival of Children with ESRD. J Am Soc Nephrol (2016) 0.79
Influence of vascular access type on sex and ethnicity-related mortality in hemodialysis-dependent patients. Perm J (2012) 0.78
Mortality risk for women on chronic hemodialysis differs by age. Can J Kidney Health Dis (2014) 0.75
Laceration of the iliac vein in a patient with a femoral catheter for hemodialysis. Int J Nephrol (2011) 0.75
Hemodialysis Disparities in African Americans: The Deeply Integrated Concept of Race in the Social Fabric of Our Society. Semin Dial (2017) 0.75
Analysis of Vascular Access in Haemodialysis Patients - Single Center Experience. J Clin Diagn Res (2015) 0.75
Correlates and variance decomposition analysis of heparin dosing for maintenance hemodialysis in older US patients. Pharmacoepidemiol Drug Saf (2014) 0.75
Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med (2006) 17.55
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol (2004) 11.23
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA (2002) 2.98
KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. Am J Kidney Dis (2013) 2.43
Predictors of delayed transition from central venous catheter use to permanent vascular access among ESRD patients. Am J Kidney Dis (2007) 2.39
Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int (2004) 2.38
A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States. Kidney Int (2004) 2.29
The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis (2006) 2.22
Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events. Hypertension (2010) 1.93
Trends in anemia management among US hemodialysis patients. J Am Soc Nephrol (2002) 1.92
Shorter dialysis times are associated with higher mortality among incident hemodialysis patients. Kidney Int (2010) 1.83
Potential cost savings of erythropoietin administration in end-stage renal disease. Am J Med (2002) 1.83
Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med (2002) 1.82
A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol (2003) 1.78
Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int (2005) 1.64
Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol (2003) 1.56
Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution. Lancet (2005) 1.54
The clinical characteristics and antiretroviral dosing patterns of HIV-infected patients receiving dialysis. Kidney Int (2003) 1.47
Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care (2010) 1.46
Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol (2003) 1.42
Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial. J Am Soc Nephrol (2005) 1.37
Does calcium kill ESRD patients--the skeptic's perspective. Nephrol Dial Transplant (2002) 1.37
Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview. Clin J Am Soc Nephrol (2007) 1.34
A low-glycemic index diet combined with exercise reduces insulin resistance, postprandial hyperinsulinemia, and glucose-dependent insulinotropic polypeptide responses in obese, prediabetic humans. Am J Clin Nutr (2010) 1.32
Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes. Diabetes Care (2013) 1.32
Interactions between dialysis-related volume exposures, nutritional surrogates and mortality among ESRD patients. Nephrol Dial Transplant (2003) 1.31
Surrogate markers in clinical studies: problems solved or created? Am J Kidney Dis (2006) 1.28
Interruption of antiretroviral therapy is associated with increased plasma cystatin C. AIDS (2009) 1.26
Kidney disease in patients with HIV infection and AIDS. Clin Infect Dis (2008) 1.25
Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis. Ann Intern Med (2006) 1.25
Nutritional status affects quality of life in Hemodialysis (HEMO) Study patients at baseline. J Ren Nutr (2002) 1.23
Variability in reasons for hemodialysis catheter use by race, sex, and geography: findings from the ESRD Clinical Performance Measures Project. Am J Kidney Dis (2008) 1.22
Effects of a CHANGE intervention to increase exercise maintenance following cardiac events. Ann Behav Med (2006) 1.18
A low-glycemic index diet and exercise intervention reduces TNF(alpha) in isolated mononuclear cells of older, obese adults. J Nutr (2011) 1.17
Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging (2012) 1.16
Hypertension Improvement Project (HIP): study protocol and implementation challenges. Trials (2009) 1.13
White blood cells as a novel mortality predictor in haemodialysis patients. Nephrol Dial Transplant (2003) 1.12
Physical function in older candidates for renal transplantation: an impaired population. Clin J Am Soc Nephrol (2009) 1.11
Randomized trial on the effects of a 7-d low-glycemic diet and exercise intervention on insulin resistance in older obese humans. Am J Clin Nutr (2009) 1.10
Enhanced expression of receptor for advanced glycation end products in chronic kidney disease. J Am Soc Nephrol (2004) 1.08
Relationship between nephrologist care and progression of chronic kidney disease. N C Med J (2007) 1.08
The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients. Kidney Int (2003) 1.05
Hypertension in pediatric long-term hemodialysis patients in the United States. Clin J Am Soc Nephrol (2009) 1.04
Receptor for advanced glycation end products on human synovial fibroblasts: role in the pathogenesis of dialysis-related amyloidosis. J Am Soc Nephrol (2002) 1.03
Appraisal of evidence and control of bias in the kidney disease outcomes quality initiative guideline development process. Clin J Am Soc Nephrol (2006) 1.01
Diabetes is the strongest risk factor for lower-extremity amputation in new hemodialysis patients. Diabetes Care (2004) 0.99
Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling. Clin J Am Soc Nephrol (2013) 0.98
Tenofovir use and urinary biomarkers among HIV-infected women in the Women's Interagency HIV Study (WIHS). J Acquir Immune Defic Syndr (2013) 0.97
Treatment strategies in patients with statin intolerance: the Cleveland Clinic experience. Am Heart J (2013) 0.97
Renal function, concomitant medication use and outcomes following acute coronary syndromes. Nephrol Dial Transplant (2005) 0.95
Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study. Am J Kidney Dis (2009) 0.95
Vector length as a proxy for the adequacy of ultrafiltration in hemodialysis. Kidney Int (2004) 0.94
Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. J Ren Nutr (2007) 0.93
New cholesterol guidelines: worth the wait? Cleve Clin J Med (2014) 0.93
Clinical course associated with vascular access type in a national cohort of adolescents who receive hemodialysis: findings from the Clinical Performance Measures and US Renal Data System projects. Clin J Am Soc Nephrol (2006) 0.92
Improving the care of ESRD patients: a success story. Health Care Financ Rev (2003) 0.91
Prevalence of kidney disease in HIV-infected and uninfected Rwandan women. PLoS One (2011) 0.90
Risk factors for early mortality in U.S. peritoneal dialysis patients: impact of residual renal function. Perit Dial Int (2002) 0.89
Regional variability in anaemia management and haemoglobin in the US. Nephrol Dial Transplant (2003) 0.89
Exercise training with weight loss and either a high- or low-glycemic index diet reduces metabolic syndrome severity in older adults. Ann Nutr Metab (2012) 0.88
Predictors of central venous catheter use at the initiation of hemodialysis. Semin Dial (2008) 0.87
Cost, quality, and value: the changing political economy of dialysis care. J Am Soc Nephrol (2007) 0.87
Diagnosis of cardiac disease in pediatric end-stage renal disease. Nephrol Dial Transplant (2010) 0.86
Disparate outcomes in pediatric peritoneal dialysis patients by gender/race in the End-Stage Renal Disease Clinical Performance Measures project. Pediatr Nephrol (2008) 0.84
Growth in adolescent hemodialysis patients: data from the Centers for Medicare & Medicaid Services ESRD Clinical Performance Measures Project. Pediatr Nephrol (2005) 0.83
The patient-centered medical home and nephrology. J Am Soc Nephrol (2009) 0.83
Developing clinical performance measures based on the Dialysis Outcomes Quality Initiative Clinical Practice Guidelines: process, outcomes, and implications. Am J Kidney Dis (2003) 0.83
A Community-Based Exercise and Support Group Program in African-American Breast Cancer Survivors (ABCs). J Phys Ther Health Promot (2013) 0.82
Sources of drug coverage among Medicare beneficiaries with ESRD. J Am Soc Nephrol (2012) 0.81
Ethnic disparity in outcomes for pediatric peritoneal dialysis patients in the ESRD Clinical Performance Measures Project. Pediatr Nephrol (2007) 0.81
Healthcare system interventions for inequality in quality: corrective action through evidence-based medicine. J Natl Med Assoc (2002) 0.81
Clinical outcomes in pediatric hemodialysis patients in the USA: lessons from CMS' ESRD CPM Project. Pediatr Nephrol (2008) 0.81
Impact of specialization of primary nephrologist on the care of pediatric hemodialysis patients. Am J Kidney Dis (2006) 0.80
Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIR. Nephrol Dial Transplant (2012) 0.80
Slowing the progression of diabetic nephropathy and its cardiovascular consequences. Am Heart J (2004) 0.80
Reduced kidney function and preclinical atherosclerosis in HIV-infected individuals: the study of fat redistribution and metabolic change in HIV infection (FRAM). Am J Nephrol (2011) 0.80
Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial). Am J Cardiol (2003) 0.79
Longitudinal analysis of intermediate outcomes in adolescent hemodialysis patients. Pediatr Nephrol (2003) 0.79
Preparing the patient for renal replacement therapy. Teamwork optimizes outcomes. Postgrad Med (2002) 0.79
A Community-Based Exercise and Support Group Program Improves Quality of Life in African-American Breast Cancer Survivors: A Quantitative and Qualitative Analysis. Int J Sports Exerc Med (2015) 0.78
Dialysis dose and gender: a different hypothesis. Kidney Int (2004) 0.78
The kinetic behaviors of urea and other marker molecules during hemodialysis. Am J Kidney Dis (2007) 0.78
Anaemia of CKD--the CHOIR study revisited. Nephrol Dial Transplant (2007) 0.78
Association of race and age with survival among patients undergoing dialysis: racial differences on many levels. Kidney Int (2011) 0.77
Perception versus reality of the burden of chronic kidney disease in the United States. J Am Soc Nephrol (2002) 0.77
Does time of day of hemodialysis affect survival? JAMA (2002) 0.75